We are live on ! Find out more
KLWA

Kelly Lawrence W & Associates Portfolio holdings

AUM $360M
1-Year Est. Return 16.9%
This Fund
S&P 500
This Quarter Est. Return
+1.44%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.66%
AUM
$433M
AUM Growth
+$33.6M
Cap. Flow
+$30.1M
Cap. Flow %
6.97%
Top 10 Hldgs %
35.53%
Holding
194
New
33
Increased
45
Reduced
29
Closed
6

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$10.3M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$8.48M
3
PE
PARSLEY ENERGY INC
PE
+$4.25M
4
CELG
Celgene Corp
CELG
+$3.67M
5
BMY icon
Bristol-Myers Squibb
BMY
+$2.26M

Top Sells

Rank Stock Value
1
AIG icon
American International
AIG
+$743K
2
AAPL icon
Apple
AAPL
+$533K
3
GE icon
GE Aerospace
GE
+$437K
4
GS icon
Goldman Sachs
GS
+$424K
5
MMM icon
3M
MMM
+$187K

Sector Composition

Rank Sector Weight
1 Healthcare 18.46%
2 Financials 16.86%
3 Technology 16.26%
4 Energy 11.68%
5 Consumer Staples 10.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLV icon
176
iShares Silver Trust
SLV
$31.5B
$5K ﹤0.01%
300
– –
AVNS
177
DELISTED
Avanos Medical
AVNS
$4K ﹤0.01%
137
– –
PC
178
DELISTED
PANASONIC CORP ADR (REP 1 SHR COM STK) (JP)
PC
$4K ﹤0.01%
465
– –
SHPG
179
DELISTED
Shire pic
SHPG
$4K ﹤0.01%
+22
New +$3.97K
BDX icon
180
Becton Dickinson
BDX
$49.2B
$1K ﹤0.01%
3
– –
NOK icon
181
Nokia
NOK
$52.6B
$1K ﹤0.01%
150
– –
ZBH icon
182
Zimmer Biomet
ZBH
$18.6B
$1K ﹤0.01%
8
– –
CC icon
183
Chemours
CC
$2.27B
$0 ﹤0.01%
11
– –
GPC icon
184
Genuine Parts
GPC
$18.8B
– –
-1,000
Closed -$99K
MRSH
185
Marsh
MRSH
$91.6B
– –
-1,700
Closed -$103K
PBI icon
186
Pitney Bowes
PBI
$2.29B
– –
-2,250
Closed -$48K
BXLT
187
DELISTED
BAXALTA INC COM STK (DE)
BXLT
– –
-150
Closed -$6K
DCUA
188
DELISTED
DOMINION RESOURCES INC. CORP UNIT 2013 SER A (VA)
DCUA
– –
-1,500
Closed -$88K
ATVI
189
DELISTED
Activision Blizzard
ATVI
$0 ﹤0.01%
6
– –
BF
190
DELISTED
BASF AKTIENGESELLT ADS(RP1 ORD
BF
– –
-1,000
Closed -$76K
FRP
191
DELISTED
FAIRPOINT COMMUNICATIONS INC.
FRP
$0 ﹤0.01%
75
– –
4 5 6 7
8

Similar funds

NC
Naman Capital Sao Paulo, Brazil $360M AUM 27.43% 1-Year Est. Return
RIP
Rhino Investment Partners West Conshohocken, Pennsylvania $359M AUM 22.33% 1-Year Est. Return
LSC
Logan Stone Capital Chicago, Illinois $360M AUM 9.71% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NI
NFC Investments Memphis, Tennessee $359M AUM 11.31% 1-Year Est. Return
RA
RR Advisors Dallas, Texas $360M AUM 28.52% 1-Year Est. Return
SWM
SK Wealth Management Providence, Rhode Island $360M AUM 14.81% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 8.03% 1-Year Est. Return

Kelly Lawrence W & Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Kelly Lawrence W & Associates held 194 positions worth $433M, up 8.4% from $399M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Kelly Lawrence W & Associates deployed $30.1M of net new capital in Q2 2016, opening 33 new positions and adding to 45 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 98,185 shares worth $8.45M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was American International, an estimated $743K trimmed.

  • Kelly Lawrence W & Associates's largest Q2 2016 buy was Vertex Pharmaceuticals: 98,185 shares worth $8.45M.
  • Kelly Lawrence W & Associates added most to Allergan plc in Q2 2016, an estimated $10.3M increase.
  • Kelly Lawrence W & Associates's biggest Q2 2016 reduction was American International, cutting an estimated $743K.
  • Kelly Lawrence W & Associates fully exited Marsh in Q2 2016, selling an estimated $103K.
  • Kelly Lawrence W & Associates's ten largest holdings make up 36% of its $433M portfolio in Q2 2016.
  • Kelly Lawrence W & Associates opened 33 new positions and closed 6 in Q2 2016.
  • Kelly Lawrence W & Associates's portfolio value rose 8.4% quarter-over-quarter to $433M.

Based on Kelly Lawrence W & Associates's 13F filing for Q2 2016, filed 15 Aug 2016.